Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00033566 | S-3304 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00459836 | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors | completed | Phase 1 | 42 | Proacta, IncorporatedINDUSTRY | 2 | Mar 2, 2011 | clinicaltrials |
| NCT00646139 |
| KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment |
| completed |
| Phase 1 |
| 7 |
| Roswell Park Cancer InstituteOTHER |
| 1 |
| Mar 2, 2011 |
| clinicaltrials |
| NCT01300468 | Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors | completed | Phase 1 | 38 | Nerviano Medical SciencesINDUSTRY | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00390936 | A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 13 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00605618 | Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00448786 | Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors | completed | Phase 1 | 49 | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00501605 | Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases | completed | Phase 1 | 80 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00556088 | LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors | completed | Phase 1 | 40 | SCRI Development Innovations, LLCOTHER | 1 | Dec 30, 2010 | clinicaltrials |
| NCT01021358 | A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). | completed | Phase 1 | 12 | AbbottINDUSTRY | 1 | Dec 20, 2010 | clinicaltrials |
| NCT01019941 | Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer(126ASC08Q) | completed | Phase 1 | 44 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 16, 2010 | clinicaltrials |
| NCT00879554 | A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors(CVX-045-101) | completed | Phase 1 | 40 | PfizerINDUSTRY | 1 | Dec 13, 2010 | clinicaltrials |
| NCT00516438 | Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan | completed | Phase 1 | 48 | AstraZenecaINDUSTRY | 1 | Dec 8, 2010 | clinicaltrials |
| NCT00413686 | Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies | completed | Phase 1 | 42 | AstraZenecaINDUSTRY | 1 | Dec 6, 2010 | clinicaltrials |
| NCT00801177 | Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy | completed | Phase 1 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00782002 | Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy | completed | Phase 1 | 27 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 30, 2010 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00778128 | A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour | completed | Phase 1 | 26 | Clavis PharmaINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00002915 | Penclomedine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00368914 | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00692354 | Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | completed | Phase 1 | 41 | Chroma TherapeuticsINDUSTRY | 0 | Aug 6, 2010 | clinicaltrials |
| NCT00730470 | Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | U3 Pharma GmbHINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00002604 | O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors | completed | Phase 1 | 28 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00005642 | SU5416 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005819 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006372 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006465 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00253344 | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00572637 | Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas | completed | Phase 1 | 55 | Ethical Oncology ScienceINDUSTRY | 2 | May 20, 2010 | clinicaltrials |
| NCT00925275 | Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors | completed | Phase 1 | 9 | Cellectar, IncINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT00618124 | A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together | completed | Phase 1 | 77 | PfizerINDUSTRY | 1 | May 3, 2010 | clinicaltrials |
| NCT00615446 | A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors | completed | Phase 1 | 44 | PfizerINDUSTRY | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00773929 | Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer | completed | Phase 1 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 27, 2010 | clinicaltrials |
| NCT00520390 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00376727 | Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00003082 | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 27 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer | completed | Phase 1 | 18 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00025454 | R115777 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Feb 8, 2010 | clinicaltrials |
| NCT00990912 | A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) | completed | Phase 1 / Phase 2 | 20 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00091325 | Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of ArizonaOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00006464 | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004220 | Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004243 | Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00006257 | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Mar 7, 2011source: clinicaltrials